Literature DB >> 1284548

Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

N Kartner1, O Augustinas, T J Jensen, A L Naismith, J R Riordan.   

Abstract

Misprocessing and mislocalization of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) has been described for the major CF-causing mutation (delta F508) in heterologous expression systems in vitro. We have generated monoclonal antibodies (mAbs) to CFTR with the aim of localizing the protein and its CF variants in vivo. Of the tissues where CFTR was observed, only the sweat gland is readily available and does not undergo secondary changes due to CF disease pathology. Sweat ducts from CF patients homozygous for delta F508 did not show the typical apical membrane staining seen in control biopsies. This demonstrates that the biosynthetic arrest and intracellular retention of delta F508 CFTR initially observed in vitro does occur in vivo and emphasizes the need to focus efforts on understanding the mislocalization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284548     DOI: 10.1038/ng0892-321

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  98 in total

1.  A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide.

Authors:  M M Hämmerle; A A Aleksandrov; X B Chang; J R Riordan
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

Review 2.  Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.

Authors:  J R Riordan
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  What happens to deltaF508 in vivo?

Authors:  M Drumm
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 4.  Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.

Authors:  Marina S Gelman; Ron R Kopito
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 5.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

6.  WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia.

Authors:  Kristopher T Kahle; Ignacio Gimenez; Hatim Hassan; Frederick H Wilson; Robert D Wong; Biff Forbush; Peter S Aronson; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

7.  WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia.

Authors:  Keith A Choate; Kristopher T Kahle; Frederick H Wilson; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-08       Impact factor: 11.205

8.  Thermal stability of purified and reconstituted CFTR in a locked open channel conformation.

Authors:  Luba A Aleksandrov; Timothy J Jensen; Liying Cui; Joseph N Kousouros; Lihua He; Andrei A Aleksandrov; John R Riordan
Journal:  Protein Expr Purif       Date:  2015-09-15       Impact factor: 1.650

9.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

10.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.